TrialEuropean journal of pain (London, England)2021

Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?

Francis Berenbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.